Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized FMT for Ulcerative Colitis
NCT01790061Phase 3Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Feb 2013
- Primary completion
- Dec 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in ulcerative colitis (UC), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Started Feb 2013; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01790061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790061.